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In an attempt to develop Complementary and Alternative Medicine (CAM) for the treatment of diabetes
and related complications, the antidiabetic potential of the mature unripe fruits of Coccinia grandis (CGF)
was evaluated. Oxidative stress and glycation plays an important role in manifesting of diabetes and
vascular complications. Agents with antioxidant and antiglycation properties may retard these patho-
logical alterations. In this study, the edible plant Coccinia grandis was assessed for in vitro estimation of
antioxidant and antiglycation potential and its insulinotrophic properties in RINm5F cells. Antioxidant
activity was evaluated as DPPH (1,1-diphenyl-2-picrylhydrazyl), hydrogen peroxide and superoxide anion
scavenging activities, whereas the protein glycation inhibitory potential was evaluated using in vitro
albumin-fructose glycation model. Glycation inhibition was estimated by different biochemical param-
eters viz. fructosamine, protein carbonyl group and protein aggregation using thioﬂavin T ﬂuorescence.
C. grandis extract exerted a dose dependent radical scavenging activity and exhibited a signiﬁcant
antiglycation potential. The extract also showed a signiﬁcant insulinotrophic property with 1.28 and 1.71-
fold increase in insulin release when compared to control at 0.25 and 0.50 mg/mL, respectively. These
data suggest the possible antidiabetic role of CGF extract, presumably by its antioxidant, antiglycation
and insulin secretory effects. Present ﬁndings provide experimental evidence that the fruits of C. grandis
have potential antidiabetic activity which might be used as a functional food and safe remedy for the
treatment of diabetes and associated complications. This study also revealed that the plant can be a
promising source for development of natural antiglycating agents and novel insulin secretagogues.
Copyright © 2016, Center for Food and Biomolecules, National Taiwan University. Production and hosting
by Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The total predicted increase in numbers of people with diabetes
from 2012 to 2030 is about 180 million (371.33 million to 551.87
million, respectively), an astonishing increase of 48% from 2012 at
an annual growth of 2.7%, which is twice the annual growth of the
total world adult population. Forty-two per cent of the anticipated
absolute global increase of 180 million people with diabetes is
projected to occur in India and China alone. According to Interna-
tional Diabetes Federation (IDF), nearly 5 million people died due tomegalai).
for Food and Biomolecules,
molecules, National Taiwan Unive
ons.org/licenses/by-nc-nd/4.0/).diabetes and its related complications in 2012.1 Therefore, novel
concepts in the management of diabetes have aroused a curiosity
among researchers throughout theworld. In countries such as India
and China, use of herbal medicines is a very common practice from
ancient time, and herbal medicines are considered to bemuch safer
and less expensive therapeutic strategies for the treatment of
various diseases. A proper scientiﬁc investigation of traditional
herbal remedies can provide valuable leads for the development of
alternative drugs and strategies for the management of diabetes.2
Role of herbs in the management and control of diabetes has
emerged fast over the years with the discovery of hypoglycemic
effect of Bitter Melon (Mormodica charantia).3,4
The human body is constantly subjected to signiﬁcant oxidative
stress as a result of an imbalance between antioxidative protective
systems and the formation of reactive oxygen species (ROS)rsity. Production and hosting by Elsevier Taiwan LLC. This is an open access article
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clinical and epidemiological ﬁndings has provided evidence sup-
porting the role of reactive oxygen species (ROS) such as singlet
oxygen, superoxide anions (O2), hydrogen peroxide (H2O2), and
hydroxyl radical (OH) in the etiology of diabetes, cardiovascular
diseases, aging etc.5 Medicinal plants and herbs are a promising and
diverse source of natural antioxidants. Many plant extracts and
plant products have been identiﬁed as good protectors against the
free radicals by triggering antioxidant gene expression. For that
account natural antioxidants from plant sources have been viewed
as promising therapeutic drugs.6
Advanced glycation end-products (AGEs) are the ﬁnal products
derived from the Maillard reaction, which is a non-enzymatic gly-
cation of free amino groups by sugars and aldehydes. AGE forma-
tion begins under hyperglycemic or oxidative stress conditions and
is characterized by conversion of reversible Schiff-base adducts to
covalently bound Amadori products, which undergo further rear-
rangements that terminate in the formation of irreversibly bound
compounds known as AGEs.7,8 The interaction of AGEs with re-
ceptors for AGEs (RAGE) directly activates multiple intracellular
signaling, gene expression, and the secretory pro-inﬂammatory
molecules accompanied by increasing free radicals that
contribute towards pathologic complications related to diabetes.9
Aminoguanidine (AG), a well-known antiglycating agent, inhibits
the formation of AGEs and prevents the development of diabetic
complications in animal models of diabetes. However, previous
studies have shown that AG has serious adverse effects in diabetes
patients, such as myocardial infarction, congestive heart failure,
arterial ﬁbrillation, anemia and gastrointestinal disturbance.10
Therefore, attention has been focused on the antioxidant and
antiglycation properties of phytochemicals present in fruits and
vegetables due to their lower toxicity and fewer side effects than
synthetic drugs. Natural antioxidants and AGE inhibitors may have
promising therapeutic potential in delaying the onset and pre-
venting diabetic complications. Many studies have shown the
beneﬁcial effect of plant-based diets for the inhibition of protein
glycation in vitro and in vivo.
Diabetes mellitus is a chronic metabolic disorder characterized
by hyperglycemia. It is believed that absolute or relative insulin
deﬁciency due to the inadequate beta cell mass is the cause of
hyperglycemia. Type 1 diabetes results from the destruction of
pancreatic beta-cells by beta-cell-speciﬁc autoimmune responses,
and type 2 diabetes results from the progressive loss of beta-cell
mass and function. Therefore, strategies that preserve or restore
beta-cell mass and function are logical therapeutic approaches for
the treatment of diabetes.11 In type I diabetes, or insulin dependent
DM (IDDM), the body has little or no insulin secretory capacity and
depends on exogenous insulin to prevent metabolic disorders and
death. While conventional treatments such as sulfonylureas, met-
formin and thiazolidinedones are effective, they have several lim-
itations, including adverse side effects, secondary failure or the
inability to halt further loss of insulin secretory capacity. Newer and
cheaper medications are therefore needed. One solution is to use
herbal remedies, which appear to be widely used with relatively
few documented side effects. In this continuing search for new
antidiabetic compounds from plants, the present study investi-
gated the antioxidant, antiglycation and insulinotrophic properties
of Coccinia grandis (L.) fruits in vitro and its possible role in pre-
vention of diabetic complications.12
Coccinia grandis (L.) Voigt belongs to the Cucurbitaceae family
and grows abundantly in India. It is a climbing perennial herb,
growing throughout India especially inwarmer and humid climatic
conditions. It is widely used in traditional treatment of diabetes.13
The fruits are used for culinary purposes as a vegetable. Scientiﬁc
investigations have supported the efﬁcacy of leaf and root extractsin amelioration of diabetic complications.14,15 C. indica leaves have
been reported to stimulate insulin secretion in diabetic rats.16 To
the best of our knowledge, there were no reports in the scientiﬁc
literature on antiglycation and insulin secreting activity of mature
unripe Coccinia grandis fruits (CGF). Hence, this study was aimed at
investigating the antioxidant and antiglycation effect of CGF in vitro
as well as to examine the effect of CGF on insulin secretion and its
cytoprotective effect using insulin-secreting Rat insulinoma clone
m5F (RINm5F) cells.Kingdom: Plantae
Order: Cucurbitales
Family: Cucurbitaceae
Genus: Coccinia
Species: C. grandis
Binomial name: C. grandis (L) J. Voigt2. Materials and methods
2.1. Cell line, chemicals and reagents
Roswell Park Memorial Institute (RPMI-1640) was procured
from Gibco and Rat insulinoma clone m5F (RINm5F) Rattus norve-
gicus (rat) cell line was obtained from the American Type Culture
Collection (ATCC). Bovine serum albumin (BSA), aminoguanidine
hydrochloride (AG), nitroblue tetrazolium (NBT), 1-deoxy-1-
morpholino-D-fructose (1-DMF), guanidine hydrochloride, thio-
ﬂavin T reagent [4-(3,6-dimethyl-1,3-benzothiazol-3-ium-2-yl)-
N,N-dimethylaniline chloride], 5,50-dithiobis(2-nitrobenzoic acid)
(DTNB) and L-cysteine were purchased from Sigma-Aldrich Co. (St.
Louis, MO, USA). Fructose, potassium dihydrogen orthophosophate,
DPPH, dipotassium hydrogen phosphate, sodium azide, trichloro-
acetic acid, hydrochloric acid, urea, ethyl alcohol, ethyl acetate,
sodium chloride were procured from Qualigens Pvt. Ltd., Mumbai,
India. All other chemicals and reagents used were of analytical
grade. All other chemicals and solvents were of analytical reagent
grade. Water was puriﬁed by Milli Q Water Puriﬁcation System,
Millipore, USA.
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Coccinia grandis (L.) Voigt mature unripe whole fruits were
collected from Southern part of India (Kancheepuram District,
Tamil Nadu, India) during the month of July 2015 and the phar-
macognostic authentication was done by Department of Plant
Sciences, University of Madras, Chennai-600 025. The fruits were
cut in to small slices, air dried under shade, pulverized to ﬁne
powder using a laboratory scale cutting mill.
2.3. Extraction procedure
The extract was prepared using themethods described by Olgica
et al.17 with minor modiﬁcations. Methanol extract was chosen
because it has been reported to be the best solvents for the
extraction of antioxidant compounds.17 The dried, ground plant
material was extracted by maceration with methanol. Fifty g of
plant material was soaked with 500 mL of the solvent for 24 h at
room temperature in a shaker. The sample was ﬁltered through
ﬁlter paper. The residue from the ﬁltration was extracted again,
twice, using the same procedure. The ﬁltrates obtained were
combined and then evaporated to dryness using a rotary evapo-
rator at 40 C. The obtained extract was stored in sterile sample
tube at -20 C.
2.4. Phytochemical analysis of CGF extract
2.4.1. Qualitative phytochemical analyses of CGF
Preliminary phytochemical analyses of the CGF extract were
done using standard procedure of Sofowora18 and Harbourne.19
2.4.2. Determination of total phenolics
The amount of total phenolics in CGF extract was determined by
the method of Singleton et al.20 with minor modiﬁcations. One
hundred mL of crude extract (20 mg/mL) was mixed with 0.2 mL of
Folin-Ciocalteu reagent, 2 mL of distilled water and 1 mL of 15%
Na2CO3. The mixture was measured at 765 nm using UV-Visible
spectrophotometer (T60U, PG Instruments Limited, UK) after 2 h at
room temperature. Gallic acid was used as a standard and the total
phenolics were expressed as mg of gallic acid equivalent (mg GAE)
per g of extract (dry weight).
2.4.3. Determination of total ﬂavonoids
Total ﬂavonoid content was determined using the method of
Chang et al.21 with some modiﬁcations using quercetin as the
standard. A calibration curve of quercetinwas prepared in the range
of 0e200 mg/mL. Brieﬂy, extract (0.5 mL) and standard (0.5 mL)
were placed in different test tubes and to each 10% aluminum
chloride (0.1 mL), 1 M potassium acetate (0.1 mL), 80% methanol
(1.5 mL) and distilled water (2.8 mL) were added and mixed. A
blank was prepared in the same manner where 0.5 mL of distilled
water was used instead of the sample or standard, and the amount
of aluminum chloride was also replaced by distilled water. All tubes
were incubated at room temperature for 30 min. The absorbance
was taken at 415 nm using UV-Visible spectrophotometer. The
concentration of ﬂavonoid was expressed as mg quercetin equiva-
lent (QE) per gram of extract.
2.4.4. Determination of saponins and dietary ﬁber content
Saponins in CGF extract was determined by standard method as
described by Anhawange et al.22 The saponins were calculated as
mg per g of extract (dry weight). The dietary ﬁber content was
analyzed by the enzymatic-gravimetric method of Asp et al.23 and
expressed as g per 100 g of plant material.2.5. Antioxidant and free radical scavenging activities of CGF (cell
free systems)
2.5.1. DPPH free radical scavenging activity
The DPPH assay was performed as described by Koleva et al.24
Approximately 10 mL of different concentrations (12.5e250 mg/
mL) of test sample solutions were added to 190 mL DPPH (150 mM)
in methanol solution. The solutions were later vortex mixed and
incubated for 20 min at 37 C. The solvent alone was considered
“blank.” The decrease in absorbance of test mixtures (due to
quenching of DPPH free radicals) was determined at 517 nm using
UV-Visible spectrophotometer; Butylated hydroxyanisole (BHA)
(12.5e250 mg/mL) was used as the standard.
DPPH scavenging activity ð%Þ ¼ ðA517 of control A517 of sampleÞ
A517 of control
 1002.5.2. Assay of hydrogen peroxide (H2O2) scavenging activity
The ability of the extract to scavenge hydrogen peroxide was
determined according to the method of Ruch et al.25 A solution of
hydrogen peroxide (2 mM) was prepared in phosphate buffer (pH
7.4). Hydrogen peroxide concentration was determined spectro-
photometrically from absorption at 230 nm. Extract samples
(12.5e250 mg/mL) were added to hydrogen peroxide solution
(0.6 mL). Absorbance of hydrogen peroxide at 230 nm was deter-
mined after 10 min against a blank solution containing phosphate
buffer without hydrogen peroxide using UVeVisible spectropho-
tometer. The percentage of scavenging of hydrogen peroxide of
both the extract and standard compound Butylated hydroxyanisole
(BHA) was determined using the following formula:
Scavenged H2O2 ð%Þ ¼
ðA0  A1Þ
A0
 100
where A0 is absorbance of the Control, and A1 is the absorbance in
the presence of the Sample or Standard (BHA).2.5.3. Assay of superoxide radical-scavenging activity
Measurement of superoxide anion-scavenging activity of the
extract was based on the method described by Liu et al.26 with
minor modiﬁcations. The reaction mixture consisted of 1.0 mL of
Nitroblue tetrazolium (NBT), 1.0 ml of NADH and 0.5 mL of an
appropriately diluted sample (12.5e250 mg/mL). The reaction was
initiated by addition of 100 ml of Phenazine methosulfate (PMS) to
the mixture. The tubes were incubated at ambient temperature for
5 min and the absorbance was measured at 560 nm in a Spectro-
photometer. The absorbance of the control was determined by
replacing the sample with methanol. BHA was used as positive
control. Decreased absorbance of the reaction mixture indicated
increased superoxide anion scavenging activity. The percentage
inhibition of superoxide anion generation was calculated using the
following formula:
% Inhibition ¼ ðA0  A1Þ
A0
 100
where A0 is absorbance of the Control, and A1 is absorbance of the
Sample or Standard (BHA).
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Glycated BSA was done according to the method of Sharma
et al.27 with minor modiﬁcations. Brieﬂy, 10 mg/mL BSA (0.50 mL)
was incubated with 0.46 mL of 500 mM fructose in 100 mM
phosphate buffered-saline (pH 7.4) containing 0.02% sodium azide
at 37 C for 4 weeks. Before incubation, 0.04 mL of different con-
centrations of CGF extract (0.0625, 0.125, 0.25 and 0.50mg/mL) and
Aminoguanidine (AG) (ﬁnal concentration: 0.50 mg/mL, positive
control) were added into the reaction mixtures. The formation of
ﬂuorescent AGEs was measured by using a spectroﬂuorometer. The
ﬂuorescent intensity was measured at an excitation wavelength of
355 nm and emission wavelength of 460 nm. The percentage of
ﬂuorescent AGE formation was calculated as follows:
Inhibition of fluorescent AGEs ð%Þ
¼ ½ðFC  FCBÞ  ðFS  FSBÞ=ðFC  FCBÞ  100
where FC and FCB were the ﬂuorescent intensity of control with
fructose and blank of control without fructose, FS and FSB were the
ﬂuorescent intensity of sample with fructose and blank of sample
without fructose.2.6.1. Determination of fructosamine
The concentration of fructosamine, the Amadori product in
glycated albumin samples and controls (after incubation for 7, 14,
21, and 28 days) was determined using a nitroblue tetrazolium
(NBT) assay according to Ardestani and Yazdanparast.28 Brieﬂy,
glycated BSA (10 mL) was incubated with 0.5 mM NBT (90 mL) in
100 mM carbonate buffer, pH 10.4 at 37 C. The absorbance was
recorded at 530 nm. The level of fructosamine was calculated by
using the different absorption at the time point of 10 and 15 min.
The level of fructosamine was calculated from a standard curve
prepared using 1-deoxy-1-morpholinofructose (1-DMF).2.6.2. Determination of protein carbonyl contents
The protein carbonyl contents were measured according to the
method of Meeprom et al.29 with minor modiﬁcations. In brief,
glycated BSA (0.10 mL) was incubated with 0.40 mL of 10 mM 2,4-
dinitrophenylhydrazine (DNPH) in 2.5 M HCl at room temperature
for 60 min. Subsequently, glycated BSAwas precipitated by 0.50 mL
of 20% (w/v) trichloroacetic acid (TCA), left on ice for 5 min and
centrifuged at 10,000 g at 4 C for 10 min. The pellet was washed
three times using 1:1 (v/v) ethanol:ethyl acetate mixture (1 mL).
The ﬁnal pellet was dissolved in 6 M guanidine hydrochloride
(0.25 mL). The absorbance was recorded at 370 nm. The level of
protein carbonyl contents was calculated by using an absorption
coefﬁcient of 22,000 M1 cm1. The results were expressed as nmol
carbonyls/mg protein.2.6.3. Determination of protein aggregation
Amyloid cross b-structure, a common marker for protein ag-
gregation was measured by using thioﬂavin T, a marker for amyloid
cross b structure according to Tupe and Agte with minor modiﬁ-
cations.30 Thioﬂavin (32 mM) was dissolved in glycine- NaOH
buffer (50 mM, pH 8.5). Glycated samples (100 mL, as described in
2.6) were incubated with thioﬂavin T solution (3 mL) for 1 h, and
the ﬂuorescence was measured at an excitation and emission
wavelength of 435 nm and 485 nm, respectively (slit, 10 nm), with
appropriate blanks devoid of thioﬂavin T. The results were
expressed as arbitrary units (AU).2.7. In vitro cytoprotective effect of CGF extract
RINm5F cells were cultured in RPMI-1640 medium supple-
mented with 10% fetal bovine serum, 1% antibiotic-antimycotic
solution and incubated at 37 C in a humidiﬁed atmosphere con-
taining 5% CO2. RINm5F cells (2  105) were incubated with CGF
extract (Concentration: 0.0625 and 0.50 mg/mL) for 24 h. After the
incubation period, the medium was removed. Cells were treated
with alloxan at 9 mM (which caused about 50% of cell death) for
1 h.31 At the end of experiment, cell viability was assessed by MTT
assay as previously described.32
2.8. Determination of the effect of CGF extract on insulin secretion
Insulin secretion by RINm5F cells was determined by the
method of Persaud et al.33 The RINm5F insulinoma cells
(1  105 cells/mL) were suspended in RPMI-1640 media supple-
mented with 10% FBS, 10 mM HEPES and 1 mM sodium pyruvate
(200 mL) into 96-well plates. Cells were incubated at 37 C in a 5%
CO2 incubator for 48 h, after which the mediumwas exchanged for
a glucose-free Krebs-Ringer bicarbonate (KRB) buffer (135 mM
NaCl, 3.6 mM KCl, 5 mM NaHCO3, 0.5 mM NaH2PO4, 0.5 mM MgCl2
and 1.5 mM CaCl2), pH 7.4 supplemented with 1 mg/ml BSA and
10 mM HEPES for a further 2 h of incubation. The medium was
subsequently replaced with 100 mL of glucose-free KRB containing
plant extract (0.0625 and 0.50 mg/mL) glibenclamide (0.1e10 mM)
or plain medium, and incubated at 37 C in a 5% CO2 for 1 h. Gli-
benclamide was dissolved in DMSO and further diluted with Kreb's
Ringer buffer. The ﬁnal concentration of DMSO (0.5% w/v) did not
affect RINm5F cell viability. Aliquots (10 mL) were removed from
eachwell, centrifuged (2000 rpm for 5min, at 4 C), and assayed for
insulin with Mercodia Rat Insulin ELISA kit as per Manufacturer's
protocol. Brieﬂy, samples (10 mL) were mixed with 100 mL enzyme
conjugate solution and incubated for 2 h on a shaker at 37 C. The
plate was washed thrice with buffer to remove unbound enzyme
labeled antibody, mixed with 200 mL of 3,30,5,50-tetrame-
thylbenzidine (TMB) and incubated for 15 min at room tempera-
ture. The reaction was stopped with 50 mL of 0.5 M sulphuric acid
and the absorbance was measured at 450 nm using Microplate
Reader (BioTek Instruments, Inc.). The insulin content of superna-
tants was determined using the following formula:34
% Insulin secreted ¼

Absorbance sample ðtreated cellsÞ
Absorbance control ðuntreated cellsÞ
 100

 100
2.9. Data analysis
All experiments were performed in triplicate. The statistical
analyses of the results were evaluated by using analysis of variance
(ANOVA) followed by Duncan's post hoc analysis. p-Values less than
0.05 were set as the level of signiﬁcance. All analyses were un-
dertaken in SPSS 16 (Statistical Package for Social Science). Data are
presented as the mean ± standard deviation of mean (SD).
3. Results
3.1. Phytochemical analysis of CGF
Phytochemical screening of CGF extract revealed the presence of
ﬂavonoids, alkaloids, glycosides, saponins, steroids, terpenoids,
tannins and phenolic compounds (Table 1). It is well known that
Table 1
Preliminary phytochemical screening of CGF extract.
S.No. Phytochemical constituent Test Inference
1. Alkaloids Wagner's Test
Mayer's Test
a
2. Carbohydrates Molisch's Test
Fehling's Test
a
3. Flavonoids Shinoda Test a
4. Glycosides Borntrager's Test
Legal's Test
KellereKilliani Test
a
5. Saponins Froth Test a
6. Steroids Salkowski reaction a
7. Tannins and Phenolic compounds Ferric Chloride Test
Lead Acetate Test
Nitric Acid Test
a
8. Terpenoids LibermanneBurchard's test a
a Indicates presence of phytochemical constituents.
Fig. 1. DPPH free radical scavenging activity of methanol extract of CGF at different
concentrations. BHA was used as a reference antioxidant. Values are expressed as
mean ± standard deviation of three independent experiments.
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products and have good health-promoting activities. Saponins are
the glycosidic compounds found in most of the plants and have
been reported to possess anticarcinogenic and antifungal activity.
In this study, the total phenolic content, ﬂavoniod contents, sapo-
nins and dietary ﬁber contents were detected in CGF extract, and
the results are shown in Table 2.
3.2. Antioxidant and free radical scavenging activities of CGF
The DPPH radicals scavenging activity demonstrate the effect of
CGF extract as antioxidant through their hydrogen donating ability,
which reduces the stable violet DPPH radical to the yellow DPPH-H.
A high percentage of radical scavenging indicated a strong antiox-
idant activity in the tested sample. The extracts showed concen-
tration dependent antiradical activity. Furthermore, the extract
which contained the considerable amount of total phenolics and
ﬂavonoids, showed a signiﬁcant effect in inhibiting DPPH, reaching
60% at a concentration of 250 mg/mL. The IC50 value (the extract
concentrationwith 50% scavenging activity) of scavenging activities
on DPPH radical was to be 0.165 mg/mL (Fig. 1).
Hydrogen peroxide scavenging activity of the CGF extract was
tested and it was increased steadily with the increasing concen-
trations. The extract signiﬁcantly scavenged up to 59.64 ± 4.22%
hydrogen peroxide at a concentration of 250 mg/mL. The ability of
the CGF extract and BHA (a reference compound) to scavenge H2O2
was compared and presented in Fig. 2.
Superoxide anion radical is an initial radical and plays an
important role in the formation of other reactive oxygen-speciesTable 2
Contents of total phenolics, ﬂavonoids, saponins and Dietary Fiber in
methanol extract of Coccinia grandis fruits (CGF).
Parameter Concentration
Yield of extract (%) 7.68 ± 0.58
Total Phenolic Contentsa 15.47 ± 1.12
Total Flavonoid Contentsb 6.82 ± 0.67
Total Saponinsc 0.12 ± 0.02
Soluble Dietary Fiberd 11.65 ± 0.93
Insoluble Dietary Fiberd 38.42 ± 1.56
Each value is expressed as mean ± SD from minimum of three inde-
pendent experiments.
a Data expressed as milligram of gallic acid equivalent (mg GAE) per g
of extract (dry weight).
b Data expressed as milligram of quercetin equivalent (mg QE) per g of
extract (dry weight).
c Data expressed as milligram per g of extract (fresh weight).
d Data expressed as gram per 100 g of plant material.such as hydroxyl radical, hydrogen peroxide or singlet oxygen in
living systems. Fig. 3 shows the superoxide anion radical scav-
enging activity of CGF extract and BHA. Signiﬁcant superoxide
anion radical scavenging activities were evident at all the tested
concentrations of the CGF. The scavenging activity was increased
with increasing concentrations.
3.3. Effect of CGF extract on the formation of ﬂuorescence AGEs
Advanced Glycation End-Products (AGEs) are signaling proteins
associated with several vascular and neurological complications inFig. 2. Hydrogen peroxide scavenging activity of methanol extract of CGF at different
concentrations. BHA was used as a reference antioxidant. Values are expressed as
mean ± standard deviation of three independent experiments.
Fig. 3. Superoxide radical scavenging activity of methanol extract of CGF at different
concentrations. BHA was used as a reference antioxidant. Values are expressed as
mean ± standard deviation of three independent experiments.
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the formation of ﬂuorescent AGEs in glycation model systems
composed by BSA and fructose treated at 37 C for 4 weeks was
evaluated. As shown in Fig. 4, the formation of AGEs was observed
weekly by themeasurement of increasing ﬂuorescent intensity. The
signiﬁcant increase in ﬂuorescent intensity in BSA incubated with
fructose was seen during 4 weeks of the incubation. The results
demonstrated that addition of CGF extract into BSA-fructose in vitro
model signiﬁcantly reduced the formation of ﬂuorescent AGE in a
concentration-dependent manner.
3.3.1. Effect of CGF extract on fructosamine level
The levels of fructosamine in glycated samples in the presence
and absence of CGF extract are shown in Fig. 5. Maximum fruc-
tosamine was formed in glycated albumin (positive control) as
compared with the negative control. Treatment of glycated samples
with CGF extract showed a signiﬁcant reduction of fructosamine
level (p< 0.05). At day 28, the percentage reduction of fructosamine
level by CGF (0.50 mg/mL) was found to be 35.03% while AG at the
same concentration of had the reduction of 38.32%.
3.3.2. The effect of CGF on protein oxidation
To access the protein oxidation mediated by glycation process,
the levels of protein carbonyl content were measured for the
duration of 4 weeks. As shown in Fig. 6, the carbonyl content ofFig. 4. The effect of CGF and aminoguanidine on ﬂuorescent AGE formation in BSA-fructose
independent experiments. a* represents signiﬁcant increase at p < 0.05 when compared t
BSA þ Fru values. cNS represents no signiﬁcant difference between BSA þ Fru and BSA þ Fru þ
aminoguanidine.fructose-glycated BSA was signiﬁcantly increased, whereas CGF
treatment signiﬁcantly suppressed an increase in protein
carbonyl content of fructose-glycated BSA. When comparing with
fructose-glycated BSA at week 4, the percentage reduction of
carbonyl content by CGF extract (0.50 mg/mL) was found to be
42.45%.
3.3.3. Effect of CGF on protein aggregation
Glycation of albumin induces the formation of amyloid ﬁbrils
which contain a cross beta structure. The property of amyloid ﬁbril
binding to speciﬁc dye thioﬂavin T, was used to quantify the level of
amyloid in glycated albumin samples. The results are depicted in
Fig. 7. It was observed that CGF extract showed signiﬁcant inhibi-
tion to amyloid aggregation (36.86% at 0.50 mg/mL concentration
on 28th day), indicating their potential to prevent conformation
changes in albumin during glycation. The reason behind decrease in
b-amyloid formation may be the low-molecular-weight bioactive
compounds such as polyphenols, phenolic acids or ﬂavonoids
which have anti-amyloidogenic effects and are likely to be present
in the extract.
3.4. In vitro cytoprotective effect of CGF extract
The protective effect of CGF extract against alloxan-induced
cell death was studied by MTT assay. The half maximal inhibi-
tory concentration (9 mM) of alloxan on cell viability was used
for studying the cytoprotective effect of the extract. It was found
that alloxan, a free radical producing agent, decreased the num-
ber of RINm5F cells. The results of MTT assay (Fig. 8) showed that
pretreatments of CGF extract provided a signiﬁcant protection
from alloxan-induced RINm5F cell damage. The extract signiﬁ-
cantly increased the cell viability to 79.45 ± 3.68% at the con-
centration of 0.50 mg/mL, when compared to alloxan alone
treated cells. The concentration of the extract was limited at
0.50 mg/mL to avoid toxicity on cell viability that may be caused
by the extract itself.
3.5. Effect of CGF extract on insulin secretion
In the present study, RINm5F cells were used to evaluate the
effect of total methanol extract from C. grandis (CGF) on insulin
secretion in vitro and the datawere shown in Fig. 9. A concentration
dependent increase in insulin secretion was observed for CGF, withsystem. Data are expressed as mean ± SD of results obtained from minimum of three
o BSA values while b* represents signiﬁcant decrease at p < 0.05 when compared to
CGF. BSA: Bovine serum albumin; Fru: Fructose; CGF: Coccinia grandis (L.) Extract; AG:
Fig. 5. The effect of CGF and aminoguanidine on the levels fructosamine in BSA-fructose system. Data are expressed as mean ± SD of results obtained from minimum of three
independent experiments. a* represents signiﬁcant increase at p < 0.05 when compared to BSA values while b* represents signiﬁcant decrease at p < 0.05 when compared to
BSA þ Fru values. cNS represents no signiﬁcant difference between BSA þ Fru and BSA þ Fru þ CGF. BSA: Bovine serum albumin; Fru: Fructose; CGF: Coccinia grandis (L.) Extract; AG:
aminoguanidine.
Fig. 6. The effect of CGF and aminoguanidine on the levels on the level protein carbonyl in BSA-fructose system. Data are expressed as mean ± SD of results obtained fromminimum
of three independent experiments. a* represents signiﬁcant increase at p < 0.05 when compared to BSA values while b* represents signiﬁcant decrease at p < 0.05 when compared
to BSA þ Fru values. cNS represents no signiﬁcant difference between BSA þ Fru and BSA þ Fru þ CGF. BSA: Bovine serum albumin; Fru: Fructose; CGF: Coccinia grandis (L.) Extract;
AG: aminoguanidine.
Fig. 7. The effect of CGF and aminoguanidine on the levels on the level on the level protein aggregation measured as thioﬂavin T ﬂuorescence in BSA-fructose system. Data are
expressed as mean ± SD of results obtained from minimum of three independent experiments. a* represents signiﬁcant increase at p < 0.05 when compared to BSA values while b*
represents signiﬁcant decrease at p < 0.05 when compared to BSA þ Fru values. cNS represents no signiﬁcant difference between BSA þ Fru and BSA þ Fru þ CGF. BSA: Bovine serum
albumin; Fru: Fructose; CGF: Coccinia grandis (L.) Extract; AG: aminoguanidine.
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Fig. 8. Cytoprotective effect of CGF extract measured as % cell viability by MTT assay. Pre-treatment with CGF extract was performed on alloxan-induced RINm5F cell damage. The
IC50 of alloxan (9 mM) was used to induce cell death after pre-treatment with CGF extract. In panel, Control is normal cells whereas Alloxan is cells treated with alloxan alone. In
panel CGFs cells were treated with CGF extract at concentrations of 62.5, 125, 250 and 500 mg/mL, respectively for 24 h before exposure of alloxan. Values are expressed as
mean ± SD of results obtained from minimum of three independent experiments. *a p < 0.05 statistically signiﬁcant difference compared to control. *b p < 0.05 statistically sig-
niﬁcant difference compared to alloxan.
Fig. 9. Insulin secreted by RIN-m5F pancreatic cells (A) expressed as percentage of untreated control cells ± SD of results obtained from minimum of three independent exper-
iments to the CGF extract and glibenclamide (positive control) in glucose free medium.
P. Meenatchi et al. / Journal of Traditional and Complementary Medicine 7 (2017) 54e64 61signiﬁcant (p < 0.05) increase from 1.193 ± 0.18 mg/L to
1.98 ± 0.24 mg/L (2.84 ± 1.4% to 70.69 ± 8.7%) from concentrations of
62.5 mg/ml to 500 mg/ml. Glibenclamide also signiﬁcantly (p < 0.05)
increased insulin secretion in a concentration dependent manner.
4. Discussion
Oxidation of DNA, lipids and proteins by ROS play an important
role in diabetes, cardiovascular disease, cancer, immune and in-
ﬂammatory disorders and many other diseases related to the aging
process.35 Diets biased towards plant-based components are
known to provide high amounts of antioxidant phytochemicals,
which offer protection against reactive oxygen species (ROS)-
induced cellular damage.36 Phytochemical screening is of para-
mount importance in identifying new source of therapeutically
valuable compounds having medicinal signiﬁcance, to make the
best and judicious use of available natural wealth.37 This study hasfocused on both the antioxidant and antidiabetic effect of C. grandis.
Screening of the CGF extract revealed the presence of phyto-
chemicals such as phenols, tannins, ﬂavonoids, saponins, steroids,
and alkaloids. The phenolic compounds are one of the largest and
most ubiquitous groups of plant metabolites and attracted a great
attention in relation to their potential for beneﬁcial effects on
health. Thus, the antioxidant and hypoglycemic activity of the CGF
extract as recorded in this studymight be attributed to the presence
of phenolic compounds and ﬂavonoids.
The dietary ﬁber content of CGF extract was analyzed by the
enzymatic-gravimetric method and the extract showed good
amounts of both soluble (11.65 ± 0.93 mg/g) and insoluble ﬁbers
(38.42 ± 1.56 mg/g). Oral administration of pectin isolated from
C. grandis fruits was shown to have a signiﬁcant hypoglycemic ef-
fect in normal rats. Pectin is a soluble ﬁber that affects blood
glucose levels either by decreasing the transit time or indirectly
through the production of short chain fatty acids (SCFAs). Acetate,
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tained by anaerobic fermentation of dietary ﬁber components by
the microﬂora in the large intestine. Thus, the high dietary ﬁber
content of CGF extract recorded in the present study correlate the
beneﬁcial effects of CGF in the diabetic condition.38,39
The DPPH free radical scavenging model can be used to evaluate
the antioxidant activity in a relatively short time. DPPH is a stable
free radical and accepts either an electron or OH to become a stable
diamagnetic molecule.40 CGF extract exhibited dose-dependent
DPPH radical scavenging activity. The extract, which contained
the considerable amount of total phenolics and ﬂavonoids, showed
a signiﬁcant effect in inhibiting DPPH, reaching ~ 60% at a con-
centration of 250 mg/mL. The IC50 value (the amount of antioxidant
material required to scavenge 50% of free radical in the assay sys-
tem) for DPPH scavenging by the CGF extract was found to be
165.69 mg/mL. Similarly, signiﬁcant H2O2 and Superoxide anion
radical scavenging activities of CGF were evident at all the tested
concentrations. The scavenging activity increased with increasing
concentration. The decrease in H2O2 concentration could help to
reduce hydroxyl radical formation and therefore reduce the effect
caused by oxidative damage. The DPPH radical, H2O2 and super-
oxide radical scavenging activities of CGF indicates the strong ca-
pacity of its constituents that can maintain sound health and
protect the human body from oxidative damage, which can induce
cancer, arteriosclerosis, arthritis, cirrhosis, inﬂammation and dia-
betes, etc.
Advanced Glycation End-Products (AGEs) are ubiquitous
signaling proteins related with vascular and neurological compli-
cations of diabetes. They include various compounds formed by the
Maillard reaction, which is a non-enzymatic glycation of free amino
groups by sugars and aldehydes. AGE formation begins under hy-
perglycemic or oxidative stress conditions and is characterized by
conversion of reversible Schiff-base adducts to covalently bound
Amadori products, which undergo further rearrangements that
terminate in the formation of irreversibly bound compounds
known as AGEs.41 Detection and measurement techniques for AGEs
have been gradually improved over the past few years, which hold a
promise for future bedside management of patients with dia-
betes.42 The reported role of AGEs in vascular complications of
diabetes and cardiovascular disease also prompted the develop-
ment of pharmacological inhibitors of their effects, giving rise to
many experimental activities and a number of both preclinical and
clinical studies.8
In the present study, the effect of CGF extract on various pa-
rameters indicative of multiple steps of albumin glycation and
mitigation of protein oxidation were assessed. The results showed
that CGF extract efﬁciently inhibited ﬂuorescent AGE formation. A
signiﬁcant increase of fructosamine, protein carbonyl content and
aggregation of proteins in BSAwere observedwhen the proteinwas
glycated by fructose. When CGF extract was added to the same
systems, it signiﬁcantly suppressed these processes. The anti-
glycation effect of CGF might be due to presence of high content of
polyphenolic (15.47 ± 1.12 mg GAE/g of extract, dry weight) com-
pounds, total ﬂavonoids (6.82 ± 0.67mgQE/g of extract, dry weight)
and saponins (0.12 ± 0.02 mg/g of extract fresh weight). The
reduction of free radical generation by antioxidant activity of
polyphenolsmay highlight majormechanisms for the prevention of
AGE formation.43 Recent studies shown that polyphenolic com-
pounds from the edible plants may play a protective role against
monosaccharide induced protein glycation.44 Kusirisin et al. have
reported a strong correlation between the polyphenolic content in
the plant extracts and the ability to inhibit protein glycation.45
According to the results obtained, it may be postulated that CGF
extract can inhibit glycation by various strategies such as (i)
blocking the early glycation product (fructosamine), (ii) reducingthe generation of reactive carbonyl or dicarbonyl groups either
from fructosamine or glucose and (iii) inhibiting the AGEs forma-
tion. The results of the study put forward the protective effect of
polyphenolic compounds of CGF against glycation induced cellular
damage and inhibition of AGEs.
Albumin, the most abundant circulating protein in the plasma
undergoes glycative alteration and the elevated level of glycated
albumin (2e3 fold) plays a vital role in the pathogenesis of vascular
complications.46 Glycation induced modiﬁcation of albumin by
fructose in prolonged incubation has been reported to form various
aggregates and amyloid-like structures causing decrease in a-he-
lices and increase in b-sheet content.47 The long-term accumula-
tion of amyloid cross b-structures in the tissues may cause the
progression of pancreatic islet amyloidosis which directly destroys
b-cell and impairs insulin secretion.48 Hence, the effect of CGF
extract on the structural modiﬁcations of BSA was evaluated. The
property of amyloid ﬁbril binding to speciﬁc dye thioﬂavin T, was
used to quantify the level of amyloid in glycated albumin samples. It
was observed that CGF extract showed signiﬁcant inhibition to
amyloid aggregation during the course of experiment, 7e28 days,
indicating their potential to prevent conformational changes in
albumin during glycation. The reason behind decrease in b-amyloid
formation may be the low-molecular-weight bioactive compounds
such as polyphenols, phenolic acids or ﬂavonoids present in the
extract which have anti-amyloidogenic effects.49 The results of this
study corroborate the effective antiglycation action of CGF extract
as they not only counteractedwith the initial glycation reaction and
its progression but also prevented amyloid cross b-structures in
BSA in vitro. This beneﬁcial effect might help to reduce the risk of
developing diabetes complications.
This report further investigated the cytoprotective potential of
CGF extract against alloxan-induced cell death using RINm5F cells
using MTT assay. The results of MTT assay (Fig. 8) showed that
pretreatments of CGF extract provided a signiﬁcant protective ef-
fect from alloxan-induced RINm5F cell damage. The results suggest
that the cytoprotective effect of CGF extract against alloxan may be
partly derived from the free radical scavenging activity of its anti-
oxidant compounds. An antidiabetic agent could exert a beneﬁcial
effect in the diabetic situation by enhancing insulin secretion and/
or by improving/mimicking insulin action.50 In this study, RINm5F
cells have been used for studying the effect of insulin secretagogues
and the insulin concentrations of the cell culture supernatant were
determined. CGF extract at 0.250 mg/mL and 0.50 mg/mL concen-
trations has signiﬁcantly increased insulin secretion and stimulated
1.28 and 1.71-fold increase in insulin secretion. The lower con-
centrations (0.0625 and 0.125 mg/mL) did not increase the insulin
secretion signiﬁcantly.
The ﬂavonoids and glycosides present in C. indica leaves are
reported to have antidiabetic effects.51,52 Triterpenes present in the
toluene extract of C. indica were shown to reduce alloxan-induced
b-cell damage and increase insulin secretion. Oral administration of
pectin isolated from C. indica fruits was shown to have a signiﬁcant
hypoglycemic effect in normal rats.53 Pectin is a soluble ﬁber that
affects blood glucose levels either by decreasing the transit time or
indirectly through the production of short chain fatty acids.38,39
From the results of this study, it can be inferred that the synergis-
tic action of the bioactive constituents present in the CGF extract
might contributed to the observed bioactivity.
5. Conclusion
With the prevalence of Coccinia grandis used both for diabetes
treatment and food, it is important to know and investigate the
possible mechanisms of its antidiabetic activity. This study inves-
tigated the potential antidiabetic activity of Coccinia grandis,
P. Meenatchi et al. / Journal of Traditional and Complementary Medicine 7 (2017) 54e64 63focussing on antioxidant activity in cell free systems; antiglycation
in BSA-fructose in vitromodel; insulin secretion and safety through
cytotoxicity assay. From the results obtained, it can be concluded
that the Coccinia grandis mature unripe fruit extract possesses
profound antioxidant, antiglycation, insulin secretory activities.
However, as this is only preliminary study, further studies are in
progress to identify the active constituents and in vivo oral rodent
efﬁcacy studies in a disease model.
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